Imperagen

Imperagen

Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.

Total raised
Undisclosed
tracked to date
Latest round
Seed
May 21, 2026
Known investors
3
led by PXN Ventures
Press coverage
2
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund DeepTech startups in United Kingdom.

Claim this profile →

🏆 Featured in Datapile’s Q2 2026 UK Funding Report

Read the Q2 2026 UK report →
Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-uk-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 UK Funding Report</a>

Funding history

  1. 1
    £5 millionSeedMay 21, 2026

    Led by PXN Ventures

    Announcement ↗

Founder

Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond
Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond

Investors in Imperagen

Backers from this company's tracked funding rounds.

  • PPXN VenturesLead investorVC firm
  • IIQ CapitalVC firm
  • NNorthern GritstoneVC firm

Imperagen in the news

Coverage of this company's funding, tracked by Datapile.

More DeepTech companies

Recently funded startups in the same category.

Related on Datapile

Imperagen — DeepTech startup in Manchester, United Kingdom | Datapile